Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID | D0K6MH | ||||
| Former ID | DNC014021 | ||||
| Drug Name | 2-(7-phenylheptanoyl)oxazole-4-carbonitrile | ||||
| Drug Type | Small molecular drug | ||||
| Indication | Discovery agent | Investigative | [529603] | ||
| Formula | C17H18N2O2 | ||||
| Canonical SMILES | C1=CC=C(C=C1)CCCCCCC(=O)C2=NC(=CO2)C#N | ||||
| InChI | 1S/C17H18N2O2/c18-12-15-13-21-17(19-15)16(20)11-7-2-1-4-8-14-9-5-3-6-10-14/h3,5-6,9-10,13H,1-2,4,7-8,11H2 | ||||
| InChIKey | IGDLMZPDBOKHRJ-UHFFFAOYSA-N | ||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529603] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
